BRIMONOCOND 0.2 % EYE DPS. 5 ML

IS A RELATIVELY SELECTIVE ALPHA-2 ADRENERGIC RECEPTOR AGONIST (TOPICAL INTRAOCULAR PRESSURE LOWERING AGENT). INDICATIONS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION. DRUG INTERACTIONS ANTIHYPERTENSIVES/CARDIAC GLYCOSIDES BECAUSE ALPHAGAN� P (BRIMONIDINE TARTRATE) MAY REDUCE BLOOD PRESSURE CAUTION IN USING DRUGS SUCH AS ANTIHYPERTENSIVES AND/OR CARDIAC GLYCOSIDES WITH ALPHAGAN� P (BRIMONIDINE TARTRATE) IS ADVISED. CNS DEPRESSANTS ALTHOUGH SPECIFIC DRUG INTERACTION STUDIES HAVE NOT BEEN CONDUCTED WITH ALPHAGAN� P (BRIMONIDINE TARTRATE) THE POSSIBILITY OF AN ADDITIVE OR POTENTIATING EFFECT WITH CNS DEPRESSANTS (ALCOHOL BARBITURATES OPIATES SEDATIVES OR ANESTHETICS) SHOULD BE CONSIDERED.